The Europe allergy immunotherapies market was valued at US$ 544.14 million in 2019 and is projected to reach US$ 1,228.14 million by 2027; it is expected to grow at a CAGR of 10.8% during the forecast period.
The allergy immunotherapies market is expected to grow owing to key driving factors such as the increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations.Allergen immunotherapy is a medical treatment useful for environmental allergies, allergies to insect bites, and asthma. Allergic disorders are the most common problems examined by primary care physicians and pediatricians, according to the International Study of Asthma and Allergies in Childhood (ISAAC), around 20% of children in the European area suffer from hay fever. The Europe Allergy Immunotherapy Market is anticipated to observe a phase of consistent growth, owing to various factors affecting the healthcare sector such as focus of government expenditure towards healthcare sector primarily in research and development accompanied by structural changes introduced into the system to enable several healthcare providers to concentrate in ensuring sufficient volume is handled. Additionally, high awareness and an increasing need for advanced treatments will further pose lucrative business growth opportunities in the foreseeable future.
The Covid-19 pandemic has harmed allergy immunotherapies market size, with small and medium scale companies struggling to sustain their businesses in the near-term future. Industry leaders are now focusing on creating new business practices to deal with crises like covid-19 pandemic.
Europe Allergy Immunotherapies Market Revenue and Forecast to 2027 (US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
EUROPE ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION
Europe Allergy Immunotherapies Market – By Treatment
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
Europe Allergy Immunotherapies Market – By Allergy Type
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Others
Europe Allergy Immunotherapies Market – By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Europe Allergy Immunotherapies Market – By Country
- UK
- Germany
- France
- Italy
- Spain
Company Profiles
- HAL Allergy B.V.
- ALK Abello A/S
Stallergenes Greer
- Anergis
Circassia
Europe Allergy Immunotherapies Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 544.14 Million |
| Market Size by 2027 | US$ 1,228.14 Million |
| Global CAGR (2019 - 2027) | 10.8% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Treatment
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment and Sublingual Immunotherapy , Allergy Type, Distribution Channel, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Europe Allergy Immunotherapies Market
- HAL Allergy B.V.
- ALK Abello A/S
- Stallergenes Greer
- Anergis
- Circassia
Get Free Sample For